Tumor growth was described to be repressed due to the disruption the fibrotic-like ECM, which led to improved infiltration of CD8+ T cells and the production of granzyme B, therefore improving anti-tumor immunity and response to immunotherapy in tumor-bearing mice (139). The gene discussed is CD8A; the disease is neoplasm.